Recent Updates
Recently added Catalysts
LLY

Lilly to Participate in Barclays Global Healthcare Conference Eli Lilly and Company (NYSE: LLY) will participate in the Barclays Global Healthcare Conference on Tuesday, March 15, 2022. Patrik Jonsson, Lilly...

Key Takeaway: INDIANAPOLIS , March 3, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will participate in the Barclays Global Healthcare Conference on Tuesday, March 15 , 2022. Patrik Jonsson, Lilly senior vice president, president of Lilly Immunology and Lilly USA , and chief customer
Price reaction · baseline $254.17 (2022-03-02 close) · hit after-hours · 1 other LLY headline(s) in the window, move may be shared
day 0 close · peak
+1.8%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus

Full Press Release Details

INDIANAPOLIS , March 3, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will participate in the Barclays Global Healthcare Conference on Tuesday, March 15 , 2022. Patrik Jonsson, Lilly senior vice president, president of Lilly Immunology and Lilly USA , and chief customer officer, will participate in a fireside chat at 10:15 a.m., Eastern time .
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 90 days.
About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news . F-LLY
Refer to: Jordan Bishop; [email protected] ; 317-473-5712 (Media)
Kevin Hern; [email protected] ; 317-277-1838 (Investors)
Last updated: Mar 3, 2022